Wong v. Iovate Health Sciences U.S.A. Inc.

Summary

The United States District Court for the Eastern District of California grants Iovate Health Sciences U.S.A. Inc.’s motion to dismiss Brandon Wong’s false-advertising class action, with leave to amend. The court dismisses plaintiff’s requests for injunctive relief and his CLRA claim because he does not allege future harm and seeks only injunctive relief under the CLRA. The court concludes that the FAL and UCL claims adequately plead the lack of an adequate legal remedy and satisfy Rule 9(b), but the excerpt ends while the court is analyzing whether the product labeling could mislead a reasonable consumer.

Holdings

1. A plaintiff seeking injunctive relief against allegedly false advertising must allege a likelihood of future harm. Because Wong did not allege future harm and sought only injunctive relief under the CLRA, the court dismissed the requests for injunctive relief and the CLRA claim.
2. At the pleading stage, allegations that the plaintiff lacks an adequate legal remedy and that equitable relief would be more prompt, certain, or efficient are sufficient to plead the lack of an adequate remedy at law.
3. The complaint adequately satisfied Rule 9(b) because it identified the defendant, the protein-content representations, the product packaging where they appeared, the approximate purchase period, and why the representations were allegedly misleading.
4. The complaint failed to state a FAL claim because the front-label asterisk and disclaimer, together with the back-label Supplement Facts panel, made it impossible for plaintiff to prove that a reasonable consumer was likely to be deceived.
5. The UCL claim failed under all three prongs. The fraudulent prong failed for the same reason as the FAL claim; the unlawful prong failed because plaintiff did not plead a viable predicate violation; and the unfair prong failed because it was based on the same conduct that did not support the other two prongs.
6. Dismissal was granted with leave to amend because the court could not conclude that amendment would be futile.

Questions Presented

1. Whether plaintiff had standing to seek injunctive relief and whether the CLRA claim, which sought only injunctive relief, should be dismissed.
2. Whether plaintiff adequately pleaded the lack of an adequate remedy at law to invoke equitable jurisdiction for his FAL and UCL claims.
3. Whether plaintiff's FAL and UCL claims satisfied Federal Rule of Civil Procedure 9(b).
4. Whether the product packaging was likely to deceive a reasonable consumer under the FAL and the fraudulent prong of the UCL.
5. Whether plaintiff stated a UCL claim under the unlawful and unfair prongs based on alleged violations of California and federal food-labeling law.

Disposition

other